These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 16619581

  • 21. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, Kuo MY, Chiang CP.
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [Abstract] [Full Text] [Related]

  • 22. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J, Okusaka T, Ohkawa S, Nagase M, Funakoshi A, Boku N, Yamao K, Yamaguchi T, Sato T.
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [Abstract] [Full Text] [Related]

  • 23. Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma.
    Kobayashi H, Koike T, Nakatsuka A, Kurita H, Sagara J, Taniguchi S, Kurashina K.
    Oral Oncol; 2005 Jan; 41(1):38-47. PubMed ID: 15598584
    [Abstract] [Full Text] [Related]

  • 24. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J, Sironen R, Juhola M, Kumpulainen E, Johansson R, Nuutinen J, Kosma VM.
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [Abstract] [Full Text] [Related]

  • 25. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 26. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE, Oliveira DT, Nonogaki S, Landman G, Carvalho AL, Kowalski LP.
    Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
    [Abstract] [Full Text] [Related]

  • 27. The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas.
    Lee SS, Yang SF, Ho YC, Tsai CH, Chang YC.
    Oral Oncol; 2008 Feb; 44(2):180-6. PubMed ID: 17418620
    [Abstract] [Full Text] [Related]

  • 28. Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.
    Sasahira T, Kirita T, Bhawal UK, Yamamoto K, Ohmori H, Fujii K, Kuniyasu H.
    Histopathology; 2007 Aug; 51(2):166-72. PubMed ID: 17593216
    [Abstract] [Full Text] [Related]

  • 29. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
    Mosleh-Shirazi MS, Mohammadianpanah M, Mosleh-Shirazi MA.
    J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
    [Abstract] [Full Text] [Related]

  • 30. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M, Tanuma J, Sugihara K, Semba I.
    Cancer; 2007 Sep 15; 110(6):1287-94. PubMed ID: 17674352
    [Abstract] [Full Text] [Related]

  • 31. [Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
    Fujimori S, Kurita H, Azegami T, Koike T, Ohtsuka A, Kobayashi H, Tanaka K, Kurashina K.
    Gan To Kagaku Ryoho; 2003 May 15; 30(5):647-52. PubMed ID: 12795096
    [Abstract] [Full Text] [Related]

  • 32. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X, Yang D, Hu J, Hao X, Gao J, Mao Z.
    Anticancer Res; 2008 May 15; 28(3A):1659-66. PubMed ID: 18630523
    [Abstract] [Full Text] [Related]

  • 33. Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma.
    Ueda G, Sunakawa H, Nakamori K, Shinya T, Tsuhako W, Tamura Y, Kosugi T, Sato N, Ogi K, Hiratsuka H.
    Int J Oral Maxillofac Surg; 2006 Apr 15; 35(4):356-61. PubMed ID: 16288849
    [Abstract] [Full Text] [Related]

  • 34. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY.
    Arch Oral Biol; 2007 Aug 15; 52(8):740-7. PubMed ID: 17331461
    [Abstract] [Full Text] [Related]

  • 35. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
    Nariai Y, Mishima K, Yoshimura Y, Sekine J.
    Int J Oral Maxillofac Surg; 2011 Apr 15; 40(4):419-26. PubMed ID: 21176871
    [Abstract] [Full Text] [Related]

  • 36. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
    Lee JI, Jin BH, Kim MA, Yoon HJ, Hong SP, Hong SD.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May 15; 107(5):678-84. PubMed ID: 19272813
    [Abstract] [Full Text] [Related]

  • 37. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
    Muñoz-Guerra MF, Marazuela EG, Fernández-Contreras ME, Gamallo C.
    Cancer; 2005 Mar 01; 103(5):960-9. PubMed ID: 15685613
    [Abstract] [Full Text] [Related]

  • 38. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Taguchi T, Tsukuda M, Mikami Y, Matsuda H, Tanigaki Y, Horiuchi C, Nishimura G, Nagao J.
    Auris Nasus Larynx; 2009 Apr 01; 36(2):199-204. PubMed ID: 18632233
    [Abstract] [Full Text] [Related]

  • 39. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma.
    Harada K, Ferdous T, Yoshida H.
    Oncol Rep; 2007 Nov 01; 18(5):1077-83. PubMed ID: 17914556
    [Abstract] [Full Text] [Related]

  • 40. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients.
    Freier K, Engel M, Lindel K, Flechtenmacher C, Mühling J, Hassfeld S, Hofele C.
    Oral Oncol; 2008 Feb 01; 44(2):116-23. PubMed ID: 17350327
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.